0001209191-16-146521.txt : 20161020
0001209191-16-146521.hdr.sgml : 20161020
20161020185918
ACCESSION NUMBER: 0001209191-16-146521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161003
FILED AS OF DATE: 20161020
DATE AS OF CHANGE: 20161020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerulean Pharma Inc.
CENTRAL INDEX KEY: 0001401914
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 204139823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-996-4300
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCKEE WILLIAM
CENTRAL INDEX KEY: 0001237262
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36395
FILM NUMBER: 161945106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-10-03
0
0001401914
Cerulean Pharma Inc.
CERU
0001237262
MCKEE WILLIAM
C/O CERULEAN PHARMA INC.
35 GATEHOUSE DRIVE
WALTHAM
MA
02451
1
0
0
0
Common Stock
2016-10-03
4
A
0
1470
1.02
A
1470
D
Consists of shares of common stock issued in lieu of cash retainers for board and committee service in accordance with an election of the reporting person under the company's non-employee director compensation program. The number of shares is equal to the amount of the cash retainers that would otherwise have been payable to the reporting person for the third fiscal quarter of 2016 divided by $1.02, the closing price of the company's common stock on the NASDAQ Global Market on October 3, 2016.
/s/ Alejandra Carvajal, as attorney-in-fact for William T. McKee
2016-10-20